Dachaigh › Leukemia Myeloid ann an Ìre Chronach › New York
Sgrùdaidhean clionaigeach Leukemia Myeloid ann an Ìre Chronach ann an New York
Tha 5 sgrùdaidhean airson Leukemia Myeloid ann an Ìre Chronach a’ lorg phàirtichean aig làraichean ann an New York.
Bailtean ann an New York
Teacsa sgrùdaidh oifigeil (Beurla)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1068, Rochester
- Ascentage Investigative Site #1053, Shirley
- Ascentage Investigative Site #1160, Stony Brook
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06423911Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
- Roswell Park Comprehensive Cancer Center, Buffalo
- Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04838041A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- NY Cancer and Blood Specialists, East Setauket
- SUNY Upstate Medical University, Syracuse
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07091019A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Medical Center, The Bronx
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT05304377A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06163430Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.